טוען...
Tumor Mutational Burden (TMB) as a Predictive Biomarker in Solid Tumors
TMB, defined as the number of somatic mutations per megabase of interrogated genomic sequence, varies across malignancies. Panel sequencing-based estimates of TMB have largely replaced whole exome sequencing-derived TMB in the clinic. Retrospective evidence suggests that TMB can predict the efficacy...
שמור ב:
| הוצא לאור ב: | Cancer Discov |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7710563/ https://ncbi.nlm.nih.gov/pubmed/33139244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2159-8290.CD-20-0522 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|